Audiologic and molecular screening for hearing loss by 35delG mutation in connexin 26 gene and congenital cytomegalovirus infection

被引:1
作者
Raul Streitenberger, Edgardo [1 ]
Ignacio Suarez, Ariel [1 ]
Veronica Masciovecchio, Maria [1 ]
Laurnagaray, Diana [2 ]
Alda, Ernesto [3 ]
机构
[1] IACA Labs, Buenos Aires, DF, Argentina
[2] Hosp Privado Sur, Serv Fonoaudiol, Buenos Aires, DF, Argentina
[3] Hosp Privado Sur, Serv Neonatol, Buenos Aires, DF, Argentina
来源
ARCHIVOS ARGENTINOS DE PEDIATRIA | 2011年 / 109卷 / 06期
关键词
congenital hearing loss; connexin; 26; CMV; PCR; DIAGNOSIS; CHILDREN; DNA;
D O I
10.5546/aap.2011.479
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction. Hearing loss may be attributed to genetic and environmental factors. Mutations in the gene of the CX26 protein (connexin 26), are responsible for 30-80% of all cases of non-syndromic profound hearing loss. The 35delG is the most frequent variant in the caucasian population. As to environmental factors, the cytomegalovirus (CMV) is the main cause of congenital infection. Objetives. To determine the prevalence of congenital CMV infection and the frequency of the 35delG mutation in newborns. To identify those at risk of suffering hearing loss in order to do an audiologic follow-up of detected cases. Materials y methods. One thousand and twenty samples of dry blood spots corresponding to newborns were tested using conventional and real time PCR. Audiologic screening was performed to all newborns before hospital discharge. Results. Fifteen out of 1020 subjects were heterozygous for the mutation. No homozygous patients were found. Six out of the samples tested positive for CMV (confirmed by a urine sample), out of which only one newborn was symptomatic. The auditory brainstem response was recorded in all these children. Hearing loss was found in three children with congenital CMV infection and two with 35delG mutation. Conclusion. The frecuency of 35delG mutation carriers in our population was 1.3% and the CMV congenital infection prevalence was 0.6%. Audiologic monitoring of these two populations allowed detection of hearing loss of late onset.
引用
收藏
页码:479 / 484
页数:6
相关论文
共 22 条
  • [1] ACMG, 2002, Genet Med, V4, P162
  • [2] Diagnosis of congenital cytomegalovirus infection by detection of viral DNA in dried blood spots
    Barbi, M
    Binda, S
    Primache, V
    Luraschi, C
    Corbetta, C
    [J]. CLINICAL AND DIAGNOSTIC VIROLOGY, 1996, 6 (01): : 27 - 32
  • [3] Bess FH, 1977, CHILDHOOD DEAFNESS C, P53
  • [4] Saliva Polymerase-Chain-Reaction Assay for Cytomegalovirus Screening in Newborns
    Boppana, Suresh B.
    Ross, Shannon A.
    Shimamura, Masako
    Palmer, April L.
    Ahmed, Amina
    Michaels, Marian G.
    Sanchez, Pablo J.
    Bernstein, David I.
    Tolan, Robert W., Jr.
    Novak, Zdenek
    Chowdhury, Nazma
    Britt, William J.
    Fowler, Karen B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (22) : 2111 - 2118
  • [5] INFECTIOUS-DISEASES SOCIETY OF AMERICA AND CENTERS FOR DISEASE-CONTROL - SUMMARY OF A WORKSHOP ON SURVEILLANCE FOR CONGENITAL CYTOMEGALOVIRUS DISEASE
    DEMMLER, GJ
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1991, 13 (02): : 315 - 329
  • [6] Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect:: implications for genetic counselling
    Denoyelle, F
    Marlin, S
    Weil, D
    Moatti, L
    Chauvin, P
    Garabédian, EN
    Petit, C
    [J]. LANCET, 1999, 353 (9161) : 1298 - 1303
  • [7] Connexin-26 mutations in sporadic and inherited sensorineural deafness
    Estivill, X
    Fortina, P
    Surrey, S
    Rabionet, R
    Melchionda, S
    D'Agruma, L
    Mansfield, E
    Rappaport, E
    Govea, N
    Milà, M
    Zelante, L
    Gasparini, P
    [J]. LANCET, 1998, 351 (9100) : 394 - 398
  • [8] Newborn hearing screening: Will children with hearing loss caused by congenital cytomegalovirus infection be missed?
    Fowler, KB
    Dahle, AJ
    Boppana, SB
    Pass, RF
    [J]. JOURNAL OF PEDIATRICS, 1999, 135 (01) : 60 - 64
  • [9] Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection
    Fowler, KB
    McCollister, FP
    Dahle, AJ
    Boppana, S
    Britt, WJ
    Pass, RF
    [J]. JOURNAL OF PEDIATRICS, 1997, 130 (04) : 624 - 630
  • [10] Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection
    Kalpoe, JS
    Kroes, ACM
    de Jong, MD
    Schinkel, J
    de Brouwer, CS
    Beersma, MFC
    Claas, ECJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (04) : 1498 - 1504